| 名稱(chēng) | PIK3CA p.G118D Reference Standard 標(biāo)準(zhǔn)品 |
| 型號(hào) | CBP10327 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | PIK3CA p.G118D Reference Standard 標(biāo)準(zhǔn)品 |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- GLP1R藥靶篩選模型應(yīng)用展示
- 非小細(xì)胞肺癌免疫治療 先放療更有效
- 血液系統(tǒng)惡性腫瘤治療研究熱點(diǎn)
- 購(gòu)買(mǎi)細(xì)胞株前需要了解的相關(guān)技術(shù)知識(shí)
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn)：ADORA2B（腺苷A2B受體）
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- 探討腫瘤細(xì)胞的“冷與熱”之分
- ctDNA液體活檢診斷標(biāo)準(zhǔn)品
- NCRI：新型檢測(cè)技術(shù)或能提前8年診斷出食管癌
- 腫瘤細(xì)胞分裂“制動(dòng)系統(tǒng)”相關(guān)基因分析
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10327PIK3CA p.G118D Reference Standard 標(biāo)準(zhǔn)品
- 詳細(xì)內(nèi)容
" _ue_custom_node_="true">
CBP10327 | |
| Format | Genomic DNA |
| Description | PIK3CA G118D lies within the region linking the PI3K-ABD and PI3K-RBD domains of the Pik3ca protein (UniProt.org). G118D confers a gain of function on the Pik3ca protein as indicated by enhanced lipid kinase activity in cell culture, increased phosphorylation of Akt in cells derived from Cowden syndrome patients harboring germline mutations (PMID: 22949682, PMID: 23246288), and increased transformation ability in two different cell lines (PMID: 29533785). |
| Technical Data | |
| DNA Change | c.353G>A |
| AA Change | p.G118D |
| Mutation type | Substitution - Missense |
| Zygosity | Heterozygous |
| Allelic Frequency | 75.00% |
| Transcript | NM_006218.1 |
| Cosmic ID | COSM751 |
| Chr position(GRCh37) | chr3:178917478 |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)